Josh Bilenker

Photo of Josh Bilenker, Partner at Aisling Capital
CompanyDeal TypeAmountDate
ViewRayPost-IPO Equity$26.7MJul 2015
LensARPrivate Equity Round$16MJan 2015
Loxo OncologySeries B$24MMay 2014
ViewRayVenture Round$30MDec 2013
LensARDebt Financing$60MOct 2013
LensARPrivate Equity Round$27MOct 2013
ViewRayVenture Round$15MMay 2013
T2 BiosystemsSeries E$40MMar 2013
Aragon PharmaceuticalsSeries D$50MOct 2012
ViewRaySeries C$45MMar 2012
No media found for Josh Bilenker.
cb
Photo of Aftab Kherani, Partner at Aisling Capital

Aisling Capital

Photo of Andrew Schiff, Managing Partner at Aisling Capital

Aisling Capital

Photo of Ayman Sabi, Partner at Aisling Capital

Aisling Capital

Photo of Dennis Purcell, Aisling Capital

Aisling Capital

Photo of Dov Goldstein, Managing Partner at Aisling Capital

Aisling Capital